UNIVERSAL BIOSENSORS SHARES SURGE AFTER FDA APPROVAL

Written on the 5 October 2016

UNIVERSAL BIOSENSORS SHARES SURGE AFTER FDA APPROVAL UNIVERSAL Biosensors (ASX:UBI) is trading up 16.95 per cent today following the US Food and Drug Administration's approval of Siemens Healthineers' Xprecia Stride Coagulation Analyzer.

The hand-held device uses test strips developed and manufactured by UBI at its Rowville facility, in Victoria, to help monitor and assess patients taking the anticoagulation drug warfarin.

Warfarin is a blood thinner and its use must be monitored carefully, as too much of the drug can lead to uncontrolled bleeding, while too little can lead to a blood clot.

The worldwide point-of-care market for coagulation testing was estimated to be worth around US$1 billion in 2014 and is forecast to grow 9 per cent per annum to $US1.4 billion by 2018.

UBI executive chairman Andrew Denver says he is thrilled patients in the US will have access to this "exceptional" device.

"We look forward to working with Siemens to help establish its place in the US market," says Denver.

The Xprecia Stride analyser was commercially launched in Europe in May 2015.

Universal Biosensors released its results for the first half of 2016 in late July, and they showed a 41 per cent growth in revenue to $10.5 million compared to the previous corresponding period.

However, revenue from sales of the Xprecia Stride Coagulation Analyzer were down 56 per cent on the pcp.

The company gets most of its revenue from its partnership with LifeScan, for which it provides its One Touch Verio blood glucose test strips.

Overall, the company made a loss of $1.2 million in the first half of this year.



Latest News

ASF UNVEILS TRAFFIC PLANS FOR THE SPIT

A SECOND bridge over the Nerang River is the centrepiece of the ASF Consortium's plan to improve traffic flow ...

BHP AND VALE EDGE CLOSER TO $47.5 BILLION SAMARCO DAM DISASTER SETTLEMENT

BHP Billiton (ASX: BHP) and Brazilian mining company Vale have entered into a preliminary agreement with Brazilian fe...

BLK SPORT FOUNDER TYRON BRANT REMAINS CEO UNDER NEW OWNERS

BLK Sport has been purchased from receivers McGrathNicol by a private consortium composed of a TimorLeste-based oi...

CARSALES CEO RETIRES AS NEW COMPETITOR COX FINALISES MERGER

CARSALES will have a new CEO as it takes on a fresh challenger to its crown as the dominant online car sales portal i...

Related News

CARSALES CEO RETIRES AS NEW COMPETITOR COX FINALISES MERGER

CARSALES will have a new CEO as it takes on a fresh challenger to its crown as the dominant online car sales portal i...

BUSINESS CONFIDENCE AT A SIX-YEAR HIGH

SMALL and medium businesses have entered 2017 with their confidence at a six-year high, building on strong gains m...

CONSUMERS PESSIMISTIC ENTERING 2017

CONSUMER confidence remains at its weakest point since April 2016, according to the latest Westpac Melbourne Institut...

RISE OF STARTUP SUPPORT PROGRAMS NOT AS ROSY AT IT SEEMS

ENTREPRENEURIAL cultivation companies in Australia are appearing quickly, but questions have been raised about whe...

Contact us

Email News Update Sign Up Contact Details
Subscriptions

PO Box 2087
Brisbane QLD 4001

LoginTell a FriendSign Up to Newsletter